These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 28942872)

  • 1. Association of sST2 and hs-CRP levels with new-onset atrial fibrillation in coronary artery disease.
    Nortamo S; Ukkola O; Lepojärvi S; Kenttä T; Kiviniemi A; Junttila J; Huikuri H; Perkiömäki J
    Int J Cardiol; 2017 Dec; 248():173-178. PubMed ID: 28942872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers as predictors of sudden cardiac death in coronary artery disease patients with preserved left ventricular function (ARTEMIS study).
    Lepojärvi ES; Huikuri HV; Piira OP; Kiviniemi AM; Miettinen JA; Kenttä T; Ukkola O; Perkiömäki JS; Tulppo MP; Junttila MJ
    PLoS One; 2018; 13(9):e0203363. PubMed ID: 30226845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular magnetic resonance-determined left ventricular myocardium impairment is associated with C-reactive protein and ST2 in patients with paroxysmal atrial fibrillation.
    Zhao L; Li S; Zhang C; Tian J; Lu A; Bai R; An J; Greiser A; Huang J; Ma X
    J Cardiovasc Magn Reson; 2021 Mar; 23(1):30. PubMed ID: 33745456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased Plasma Concentrations of Soluble ST2 Independently Predict Mortality but not Cardiovascular Events in Stable Coronary Heart Disease Patients: 13-Year Follow-up of the KAROLA Study.
    Pfetsch V; Sanin V; Jaensch A; Dallmeier D; Mons U; Brenner H; Koenig W; Rothenbacher D
    Cardiovasc Drugs Ther; 2017 Apr; 31(2):167-177. PubMed ID: 28283847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Supraventricular premature beats and risk of new-onset atrial fibrillation in coronary artery disease.
    Nortamo S; Kenttä TV; Ukkola O; Huikuri HV; Perkiömäki JS
    J Cardiovasc Electrophysiol; 2017 Nov; 28(11):1269-1274. PubMed ID: 28744977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble ST2 in Patients with Nonvalvular Atrial Fibrillation and Prediction of Heart Failure.
    Chen C; Qu X; Gao Z; Zheng G; Wang Y; Chen X; Li H; Huang W; Zhou H
    Int Heart J; 2018 Jan; 59(1):58-63. PubMed ID: 29279523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of sinus rhythm restoration on high-sensitivity C-reactive protein levels and their association with long-term atrial fibrillation recurrence after electrical cardioversion.
    Celebi OO; Celebi S; Canbay A; Ergun G; Aydogdu S; Diker E
    Cardiology; 2011; 118(3):168-74. PubMed ID: 21654170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation of C-reactive protein to the first onset and the recurrence rate in lone atrial fibrillation.
    Hatzinikolaou-Kotsakou E; Tziakas D; Hotidis A; Stakos D; Floros D; Papanas N; Chalikias G; Maltezos E; Hatseras DI
    Am J Cardiol; 2006 Mar; 97(5):659-61. PubMed ID: 16490433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers for Predicting the Occurrence and Progression of Atrial Fibrillation: Soluble Suppression of Tumorigenicity 2 Protein and Tissue Inhibitor of Matrix Metalloproteinase-1.
    Sun WP; Du X; Chen JJ
    Int J Clin Pract; 2022; 2022():6926510. PubMed ID: 36683600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation between soluble ST2, growth differentiation factor-15, and high-sensitivity troponin I and incident atrial fibrillation.
    Rienstra M; Yin X; Larson MG; Fontes JD; Magnani JW; McManus DD; McCabe EL; Coglianese EE; Amponsah M; Ho JE; Januzzi JL; Wollert KC; Fradley MG; Vasan RS; Ellinor PT; Wang TJ; Benjamin EJ
    Am Heart J; 2014 Jan; 167(1):109-115.e2. PubMed ID: 24332149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic implications of the high-sensitive C-reactive protein in the catheter ablation of atrial fibrillation.
    Lin YJ; Tsao HM; Chang SL; Lo LW; Tuan TC; Hu YF; Udyavar AR; Tsai WC; Chang CJ; Tai CT; Lee PC; Suenari K; Huang SY; Nguyen HT; Chen SA
    Am J Cardiol; 2010 Feb; 105(4):495-501. PubMed ID: 20152244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterisation and validity of inflammatory biomarkers in the prediction of post-operative atrial fibrillation in coronary artery disease patients.
    Kaireviciute D; Blann AD; Balakrishnan B; Lane DA; Patel JV; Uzdavinys G; Norkunas G; Kalinauskas G; Sirvydis V; Aidietis A; Lip GY
    Thromb Haemost; 2010 Jul; 104(1):122-7. PubMed ID: 20458440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory markers according to types of atrial fibrillation.
    Gedikli O; Dogan A; Altuntas I; Altinbas A; Ozaydin M; Akturk O; Acar G
    Int J Cardiol; 2007 Aug; 120(2):193-7. PubMed ID: 17240468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-sensitivity troponin T level and angiographic severity of coronary artery disease.
    Ndrepepa G; Braun S; Schulz S; Mehilli J; Schömig A; Kastrati A
    Am J Cardiol; 2011 Sep; 108(5):639-43. PubMed ID: 21676369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer antigen-125 plasma level as a biomarker of new-onset atrial fibrillation in postmenopausal women.
    Sekiguchi H; Shimamoto K; Takano M; Kimura M; Takahashi Y; Tatsumi F; Watanabe E; Jujo K; Ishizuka N; Kawana M; Hagiwara N
    Heart; 2017 Sep; 103(17):1368-1373. PubMed ID: 28285269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-sensitivity troponin T and risk stratification in patients with atrial fibrillation during treatment with apixaban or warfarin.
    Hijazi Z; Wallentin L; Siegbahn A; Andersson U; Alexander JH; Atar D; Gersh BJ; Hanna M; Harjola VP; Horowitz JD; Husted S; Hylek EM; Lopes RD; McMurray JJ; Granger CB;
    J Am Coll Cardiol; 2014 Jan 7-14; 63(1):52-61. PubMed ID: 24055845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of Highly Sensitive Troponin as a Predictor of Short-Term Outcome in Patients With Diabetes Mellitus and Stable Coronary Artery Disease (from the ARTEMIS Study).
    Lepojärvi ES; Piira OP; Kiviniemi AM; Miettinen JA; Kenttä T; Ukkola O; Tulppo MP; Huikuri HV; Junttila MJ
    Am J Cardiol; 2016 Feb; 117(4):515-521. PubMed ID: 26739392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated soluble ST2 concentration may involve in the progression of atrial fibrillation.
    Ma X; Yuan H; Luan HX; Shi YL; Zeng XL; Wang Y
    Clin Chim Acta; 2018 May; 480():138-142. PubMed ID: 29428199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Usefulness of high-sensitivity CRP increases during circadian rhythm for prediction of long-term cardiovascular events in patients with stable coronary artery disease].
    Koç M; Sahin DY; Uysal OK; Karaarslan O; Dönmez E; Abalı G; Batur MK
    Turk Kardiyol Dern Ars; 2011 Oct; 39(7):568-75. PubMed ID: 21983767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High sensitive C-reactive protein and interleukin 6 in atrial fibrillation with rheumatic mitral stenosis from Indian cohort.
    Sharma G; Shetkar S; Bhasin A; Ramakrishnan L; Juneja R; Naik N; Roy A; Ramakrishnan S; Bhargava B; Bahl VK
    Indian Heart J; 2017; 69(4):505-511. PubMed ID: 28822519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.